Holly Brown

1.1k total citations
31 papers, 553 citations indexed

About

Holly Brown is a scholar working on Oncology, Otorhinolaryngology and Clinical Psychology. According to data from OpenAlex, Holly Brown has authored 31 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 6 papers in Otorhinolaryngology and 6 papers in Clinical Psychology. Recurrent topics in Holly Brown's work include Cancer Immunotherapy and Biomarkers (12 papers), Head and Neck Cancer Studies (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Holly Brown is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Head and Neck Cancer Studies (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Holly Brown collaborates with scholars based in United States, Belgium and Canada. Holly Brown's co-authors include Harry Strothers, Jo Taylor, Joseph G. Ouslander, Christine K. Gause, Jonathan D. Cheng, Robert J. Reese, Patricia A. Parmelee, Barbara Burtness, Dani E. Rosenkrantz and Josep Tabernero and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Holly Brown

30 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Holly Brown United States	13	208	96	94	82	77	31	553
Zeeshan Qadri Saudi Arabia	14	112 0.5×	84 0.9×	137 1.5×	32 0.4×	51 0.7×	32	807
Emily K. Hill United States	12	202 1.0×	75 0.8×	100 1.1×	27 0.3×	49 0.6×	29	596
Linda Sutton United States	15	475 2.3×	91 0.9×	125 1.3×	71 0.9×	102 1.3×	45	948
Lili Tang China	14	264 1.3×	83 0.9×	150 1.6×	40 0.5×	92 1.2×	41	595
Cindy Melancon United States	10	500 2.4×	94 1.0×	84 0.9×	27 0.3×	66 0.9×	11	1.0k
Michele Carlo Schiavi Italy	18	105 0.5×	26 0.3×	77 0.8×	42 0.5×	45 0.6×	63	940
Margaret Barton‐Burke United States	13	325 1.6×	76 0.8×	81 0.9×	69 0.8×	112 1.5×	51	631
Soon Nam Lee South Korea	15	195 0.9×	125 1.3×	93 1.0×	30 0.4×	104 1.4×	47	691
Ghasem Janbabai Iran	14	326 1.6×	20 0.2×	60 0.6×	62 0.8×	145 1.9×	64	683
Mahboob Sobhan United States	9	142 0.7×	29 0.3×	26 0.3×	86 1.0×	134 1.7×	10	734

Countries citing papers authored by Holly Brown

Since Specialization

Citations

This map shows the geographic impact of Holly Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Brown more than expected).

Fields of papers citing papers by Holly Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Brown. The network helps show where Holly Brown may publish in the future.

Co-authorship network of co-authors of Holly Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Brown. A scholar is included among the top collaborators of Holly Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Brown. Holly Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown, Holly, et al.. (2019). Blessing or BS? The therapy experiences of transgender and gender nonconforming clients obtaining referral letters for gender affirming medical treatment.. Professional Psychology Research and Practice. 51(6). 571–579. 22 indexed citations

Siu, Lillian L., Lisa Licitra, Chia‐Jui Yen, et al.. (2018). Abstract CT163: KEYNOTE-412: Pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma. Cancer Research. 78(13_Supplement). CT163–CT163. 4 indexed citations

Reese, Robert J., et al.. (2017). Patient feedback as a quality improvement strategy in an acute care, inpatient unit: An investigation of outcome and readmission rates.. Psychological Services. 15(4). 470–476. 12 indexed citations

Machiels, J-P., C-J. Yen, Lisa Licitra, et al.. (2017). Phase 3 KEYNOTE-412 trial: Pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Annals of Oncology. 28. xi28–xi28.

Mark, Kristen P., et al.. (2017). Validation of the Sexual Desire Inventory for lesbian, gay, bisexual, trans, and queer adults.. Psychology of Sexual Orientation and Gender Diversity. 5(1). 122–128. 29 indexed citations

Machiels, Jean‐Pascal, Lisa Licitra, Danny Rischin, et al.. (2017). KEYNOTE-412: Pembrolizumab (pembro) in combination with chemoradiation versus chemoradiation alone in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).. Journal of Clinical Oncology. 35(15_suppl). TPS6090–TPS6090. 10 indexed citations

Reese, Robert J., et al.. (2016). The effects of telepsychology format on empathic accuracy and the therapeutic alliance: An analogue counselling session. Counselling and Psychotherapy Research. 16(4). 256–265. 35 indexed citations

Powell, Steven, Stephen V. Liu, Ammar Sukari, et al.. (2015). KEYNOTE-055: A phase II trial of single agent pembrolizumab in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) who have failed platinum and cetuximab.. Journal of Clinical Oncology. 33(15_suppl). TPS3094–TPS3094. 9 indexed citations

Cohen, Ezra E.W., Jean‐Pascal Machiels, Kevin J. Harrington, et al.. (2015). KEYNOTE-040: A phase III randomized trial of pembrolizumab (MK-3475) versus standard treatment in patients with recurrent or metastatic head and neck cancer.. Journal of Clinical Oncology. 33(15_suppl). TPS6084–TPS6084. 28 indexed citations

10.

Bellmunt, Joaquim, Guru Sonpavde, Ronald de Wit, et al.. (2015). KEYNOTE-045: Randomized phase 3 trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel, or vinflunine for previously treated metastatic urothelial cancer.. Journal of Clinical Oncology. 33(15_suppl). TPS4571–TPS4571. 11 indexed citations

11.

Bajorin, Dean F., Elizabeth R. Plimack, Arlene O. Siefker‐Radtke, et al.. (2015). KEYNOTE-052: Phase 2 study of pembrolizumab (MK-3475) as first-line therapy for patients (pts) with unresectable or metastatic urothelial cancer ineligible for cisplatin-based therapy.. Journal of Clinical Oncology. 33(15_suppl). TPS4572–TPS4572. 9 indexed citations

12.

Miller, Rachel W., Edward J. Pavlik, Lauren Baldwin, et al.. (2015). Complications from surgeries prompted by ovarian cancer screening. Gynecologic Oncology. 137. 180–180. 3 indexed citations

13.

Morán, Teresa, Enriqueta Felip, Vicki L. Keedy, et al.. (2014). Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trial. Experimental Hematology and Oncology. 3(1). 26–26. 27 indexed citations

14.

Parmelee, Patricia A., et al.. (2008). “Sometimes People Don't Fit in Boxes”: Attitudes Toward the Minimum Data Set Among Clinical Leadership in VA Nursing Homes. Journal of the American Medical Directors Association. 10(2). 98–106. 19 indexed citations

15.

Atzori, Francesco, Josep Tabernero, Andrés Cervantes, et al.. (2008). A phase I, pharmacokinetic (PK) and pharmacodynamic (PD) study of weekly (qW) MK-0646, an insulin-like growth factor-1 receptor (IGF1R) monoclonal antibody (MAb) in patients (pts) with advanced solid tumors. Journal of Clinical Oncology. 26(15_suppl). 3519–3519. 47 indexed citations

16.

Rask, Kimberly J., Patricia A. Parmelee, Jo Taylor, et al.. (2007). Implementation and Evaluation of a Nursing Home Fall Management Program. Journal of the American Geriatrics Society. 55(3). 342–349. 54 indexed citations

17.

Capezuti, Elizabeth, Jo Taylor, Holly Brown, Harry Strothers, & Joseph G. Ouslander. (2007). Challenges to implementing an APN-facilitated falls management program in long-term care. Applied Nursing Research. 20(1). 2–9. 29 indexed citations

18.

Brown, Holly & James S. Elliot. (1969). Bladder Cancer: An Evaluation of Diagnosis and Treatment of 93 Patients. The Journal of Urology. 102(1). 63–66. 7 indexed citations

19.

Brown, Holly, Robert Finney, William G. Smith, et al.. (1959). GLYCYRRHETINIC ACID HYDROGEN SUCCINATE (DISODIUM SALT). The Lancet. 274(7101). 492–493. 14 indexed citations

20.

Brown, Holly, et al.. (1959). Effects of Methylandrostenediol, Methyltestosterone and Thyroprotein on Growth and Carcass Characteristics of Swine. Journal of Animal Science. 18(4). 1189–1195. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact